Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 3,169-3,180 of 10,592
Behavioral study icon
TerminatedNCT01733680

Amiloride Hydrochloride as an Effective Treatment for ADHD

This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In United States
ADHDBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
State University of New York - Upstate Medical University
Condition
ADHD
Behavioral study icon
CompletedNCT00343928

Amino Acids, Serotonin, and Body Weight Regulation

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Eating disordersBehavioralFrom 18 Years to 40 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Eating disorders
Other study type icon
Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

This observational study is following people with Clinical High Risk, Psychosis, Remission, or Conversion to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
SchizophreniaOtherFrom 12 Years to 30 Years
Countries
United States, Australia, Canada, ...
Sponsor
Brigham and Women's Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT03834766

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

Remote / online
ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Tris Pharma, Inc.
Condition
ADHD
Drug study icon
CompletedNCT03055338

An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

This study exists to understand how the medication Elpipodect holds up over time after the earliest research stage. Researchers are trying to understand whether the medication Elpipodect can give earlier or clearer feedback during care.

In United States
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.